Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
about
Mutant p53 disrupts mammary tissue architecture via the mevalonate pathwayObesity and cancer: mechanistic insights from transdisciplinary studiesMolecular cancer prevention: Current status and future directionsPlant sterols as anticancer nutrients: evidence for their role in breast cancerCurrent and Emerging Uses of Statins in Clinical Therapeutics: A ReviewUtilization of genomic signatures to identify phenotype-specific drugsCancer risk in older people receiving statin therapy: a meta-analysis of randomized controlled trialsLigand Activation of ERRα by Cholesterol Mediates Statin and Bisphosphonate EffectsSimvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with postmastectomy radiation.Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.Dysregulation of the mevalonate pathway promotes transformationLipophilic statin use and risk of breast cancer subtypes.Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifenStatin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.Quantitative proteomic analysis revealed lovastatin-induced perturbation of cellular pathways in HL-60 cells.Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease.Statin use and breast cancer survival: a nationwide cohort study in Scotland.Chemoprevention of hormone receptor-negative breast cancer: new approaches neededIntensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis.Effects of Lovastatin on MDA-MB-231 Breast Cancer Cells: An Antibody Microarray Analysis.Statin Use and Breast Cancer Risk in the Nurses' Health Study.Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.Statins and breast cancer stage and mortality in the Women's Health Initiative.Statins and breast cancer: may matrix metalloproteinase be the missing link.Statins and risk of breast cancer recurrence.Targeting tumor cell metabolism with statins.Statin-induced inhibition of breast cancer proliferation and invasion involves attenuation of iron transport: intermediacy of nitric oxide and antioxidant defence mechanisms.Mevalonate pathway is a therapeutic target in esophageal squamous cell carcinoma.Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.p53 and cancer stem cells: the mevalonate connexion.Simvastatin induces estrogen receptor-alpha expression in bone, restores bone loss, and decreases ERα expression and uterine wet weight in ovariectomized rats.Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration.
P2860
Q24302433-986AE905-6DB7-4D21-9AD7-53EB835481BFQ26786829-8AE63826-F35D-4730-AAED-74305FC29AA2Q26797207-18268A14-6EDF-4831-91C0-80104EAABF8DQ26861053-5FBEFB0F-7938-4E07-B1FF-6D6240F345AAQ28076346-2F310D12-D9D6-489F-905F-9C954D62C6B8Q28476014-DE8EE197-A081-4C28-A79E-3396C29954FBQ28821882-4D0CF43F-2494-44E2-ACB4-526D988103F8Q29027212-F3D62661-0592-4316-A56A-230FE3FAC96DQ33816245-E08C4345-B9B0-4333-A668-0192E725023FQ33826605-B6E04A8F-0F7F-44EA-B704-BA5DFD9C26FEQ33864834-62735BCB-3C5D-4ACB-8CB6-C24A8F387694Q33889477-1DD84506-DF2B-4BCE-884C-91DD7C3852F3Q33901385-2D3574D7-0A34-4665-A30C-F4055272C0F6Q34093736-3FFECB98-FF6B-4EE0-BC22-87294694EF02Q34185642-D320400F-33A5-4074-BF37-62BD3C2831DEQ35029556-F3663417-BAD1-41A5-8AF2-E3A7F6859BF6Q35268601-22696883-E402-4287-B554-358E3487F1D4Q35592559-DAEA40F6-FC3A-4460-BD3B-8B82BB068CC9Q35673791-54CBF44C-E328-4DE8-B678-B19A773B93E9Q35910859-4EF0D1CB-CD07-45E0-9958-8875B06280FDQ36095264-935B9D53-C565-4963-89F6-C970FC4B5901Q36153371-E741878F-20AD-4F35-B3BC-7405B7AC9D2CQ36243281-7587C5E4-CA9C-4A87-898F-0830582B693EQ36473929-4D0C06F3-89AD-47EB-B9F2-11D6999367D4Q36828174-D42B78AD-3F22-4DA9-B4A4-537635B52B81Q37038650-E46B7B19-5038-435A-9FAD-9FDCE559276AQ37137519-6978A752-26E6-4911-9A0B-2AD27C459CF4Q37267573-19F9390A-CD1C-43DD-9C23-8A426D563D5CQ37324459-EB50A2AF-17D8-4723-AD6E-F9E9A059E0E6Q37393969-7B9D92D3-9FEF-48A4-933D-CD5CA7A26A7DQ37407449-D457C9F6-E6E5-4DDE-8FC9-6224999059D3Q37981833-CF603136-7273-42AC-A019-E12E8589947AQ38981350-3DABD5FF-4411-4F28-AC5F-93278F099631Q39239195-F197B168-88D3-4BB4-B259-5AD7A1F314FEQ39455228-27F5ECE2-2944-4411-A3B9-5BD4DEEB055AQ43234576-8CEA4474-7A78-4B0D-9877-04D04A39CA67Q47406325-00002CF9-D818-48C5-9916-7A71E076B276Q54331848-68AFE53B-A824-4F2F-B0B4-E1C191B79E7D
P2860
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Estrogen receptor-negative bre ...... among lipophilic statin users.
@en
Estrogen receptor-negative bre ...... among lipophilic statin users.
@nl
type
label
Estrogen receptor-negative bre ...... among lipophilic statin users.
@en
Estrogen receptor-negative bre ...... among lipophilic statin users.
@nl
prefLabel
Estrogen receptor-negative bre ...... among lipophilic statin users.
@en
Estrogen receptor-negative bre ...... among lipophilic statin users.
@nl
P2093
P1476
Estrogen receptor-negative bre ...... among lipophilic statin users.
@en
P2093
Anjali S Kumar
Christina A Minami
Christopher C Benz
Dan H Moore
Laura J Esserman
Veronica Shim
P304
P356
10.1158/1055-9965.EPI-07-0726
P577
2008-05-07T00:00:00Z